Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China
European Journal of Endocrinology · 2023
DOI: 10.1093/ejendo/lvac019 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Yin Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Premature Birth, Pregnancy Complications, Diabetes, Gestational. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Objective
We aimed to investigate the associations between maternal fasting plasma glucose (FPG) levels and glycemic fluctuations during different trimesters and adverse birth outcomes among newborns.
Methods
This cohort study used data from 63 213 pregnant women and their offspring in Foshan city from November 2015 to January 2019. Associations between maternal FPG and glycemic fluctuations during different trimesters and adverse birth outcomes [congenital heart defect (CHD), macrosomia, small/large for gestational age (SGA/LGA), and preterm birth (PTB)] in newborns were estimated using mixed-effects logistic regression models.
Results
A total of 45 516 participants accepted at least one FPG test throughout pregnancy, and 7852 of whom had glycemic trajectory data. In the adjusted model, higher maternal FPG throughout the pregnancy was associated with an increased risk of adverse birth outcomes (except for SGA). Each 1 mmol/L increase in maternal FPG during trimester 1 was associated with higher odds of CHD (OR = 1.14 (95% CI: 1.02, 1.26)). The same increase in maternal FPG during trimester 3 was associated with a higher risk of PTB (OR = 1.05 (95% CI: 1.01, 1.10)). Increment of maternal FPG during trimester 2 and trimester 3 was associated with a higher risk of macrosomia and LGA. Increase in FPG throughout the pregnancy was associated with slightly lower odds of SGA. Similar results were observed when analyzing the associations between glycemic fluctuations during different trimesters and adverse birth outcomes.
Conclusions
Our findings indicate higher maternal FPG levels during different trimesters were associated with different adverse birth outcomes, which suggests the importance of glycemic management throughout the pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
- Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan 528000, China.
ORCID-Profile: Yin Yang, Zilong Zhang, Hualiang Lin
Zitieren
APA
Yang, Y., Lin, Q., Ma, L., Lai, Z., Xie, J., Zhang, Z., Wu, X., Luo, W., Hu, P., Wang, X., Guo, X., & Lin, H. (2023). Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvac019
Vancouver
Yang Y, Lin Q, Ma L, Lai Z, Xie J, Zhang Z, et al. Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvac019
BibTeX
@article{Yang2023,
author = {Yang, Yin and Lin, Qingmei and Ma, Liming and Lai, Zhihan and Xie, Junxing and Zhang, Zilong and Wu, Xueli and Luo, Weidong and Hu, Pengzhen and Wang, Xing and Guo, Xiaoling and Lin, Hualiang},
title = {Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China},
journal = {European Journal of Endocrinology},
year = {2023},
doi = {10.1093/ejendo/lvac019}
}
EUVIMED